Objective To provide an update on key safety metrics after transfusion of convalescent plasma
in hospitalized coronavirus 2019 (COVID-19) patients, having previously demonstrated …

BACKGROUND Convalescent plasma is the only antibody-based therapy currently available
for patients with coronavirus disease 2019 (COVID-19). It has robust historical precedence …

Background Convalescent plasma has been widely used to treat coronavirus disease 2019 (Covid-19)
under the presumption that such plasma contains potentially therapeutic …

Importance Passive antibody transfer is a longstanding treatment strategy for infectious
diseases that involve the respiratory system. In this context, human convalescent plasma has …

To determine the effect of COVID-19 convalescent plasma on mortality, we aggregated
patient outcome data from 10 randomized clinical trials, 20 matched control studies, 2 dose-…

Tumour cell phagocytosis by antigen presenting cells (APCs) is critical to the generation of
antitumour immunity. However, cancer cells can evade phagocytosis by upregulating anti-…

Background The diagnosis of acute myocarditis typically requires either endomyocardial
biopsy (which is invasive) or cardiovascular magnetic resonance imaging (which is not …

In the past decade there has been a growing interest in understanding sex and gender
differences in myocarditis and dilated cardiomyopathy (DCM), and the purpose of this review is to …

In the absence of effective countermeasures, human convalescent plasma has been widely
used to treat severe acute respiratory syndrome coronavirus 2, the causative agent of novel …

Extracellular vesicles (EVs) are released from all cells in the body, forming an important
intercellular communication network that contributes to health and disease. The contents of EVs …